Author

Susan B. Connelly 1

1 Pfizer Inc,Collegeville,United States

CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL PROGRAMME

Daniel C. Baumgart, Chinyu Su, Kenneth Kwok, Jami A. Kinnucan, Xiang Guo, Susan B. Connelly, Edward V. Loftus Jr., Krisztina B. Gecse, Alessandro Armuzzi

EVALUATION OF THE EFFICACY OF TOFACITINIB AS MAINTENANCE THERAPY IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY OCTAVE SUSTAIN BASELINE ENDOSCOPIC SUBSCORE

Susan B. Connelly, Nervin Lawendy, Jerome Paulissen, Krisztina Barbara Gecse, Scott Lee, Flavio Steinwurz, Jessica Allegretti

MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: FINAL RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN

Walter Reinisch, Jean-Frédéric Colombel, Mark T. Osterman, Patricio Ibáñez, Severine Vermeire, Peter Irving, Susan B. Connelly, Rajiv Mundayat, Nervin Lawendy, Sean Gardiner, Chinyu Su

Item 1 - 3 / 3
1